Milroy Disease
Symptoms, Doctors, Treatments, Advances & More

Learn About Milroy Disease

What is the definition of Milroy Disease?

Milroy disease is a condition that affects the normal function of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. Impaired transport with accumulation of lymph fluid can cause swelling (lymphedema). Individuals with Milroy disease typically have lymphedema in their lower legs and feet at birth or develop it in infancy. The lymphedema typically occurs on both sides of the body and may worsen over time.

What are the causes of Milroy Disease?

Mutations in the FLT4 gene cause some cases of Milroy disease. The FLT4 gene provides instructions for producing a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. Mutations in the FLT4 gene interfere with the growth, movement, and survival of cells that line the lymphatic vessels (lymphatic endothelial cells). These mutations lead to the development of small or absent lymphatic vessels. If lymph fluid is not properly transported, it builds up in the body's tissues and causes lymphedema. It is not known how mutations in the FLT4 gene lead to the other features of this disorder.

How prevalent is Milroy Disease?

Milroy disease is a rare disorder; its incidence is unknown.

Is Milroy Disease an inherited disorder?

Milroy disease is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In many cases, an affected person inherits the mutation from one affected parent. Other cases may result from new mutations in the FLT4 gene. These cases occur in people with no history of the disorder in their family. About 10 percent to 15 percent of people with a mutation in the FLT4 gene do not develop the features of Milroy disease.

Who are the top Milroy Disease Local Doctors?
Distinguished in Milroy Disease
Vascular Surgery | General Surgery
Distinguished in Milroy Disease
Vascular Surgery | General Surgery
Referral may be required

Texas Health Heart, Lung And Vascular Surgical Specialists

Denton, TX 
Languages Spoken:
English, Spanish

Raul Ortega is a Vascular Surgeon and a General Surgeon practicing medicine in Denton, Texas. Dr. Ortega is rated as a Distinguished provider by MediFind in the treatment of Milroy Disease. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lymphedema-Distichiasis Syndrome, Milroy Disease, Aagenaes Syndrome, Carotid Artery Surgery, and Endoscopy.

Elite in Milroy Disease
Elite in Milroy Disease
Referral may be required
Tokyo, JP 

Takumi Yamamoto practices practicing medicine in Tokyo, Japan. Mr. Yamamoto is rated as an Elite expert by MediFind in the treatment of Milroy Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lymphedema, Milroy Disease, Breast Cancer, Mastectomy, and Ileostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Milroy Disease
Elite in Milroy Disease
Referral may be required
Tokyo, JP 

Hisako Hara practices practicing medicine in Tokyo, Japan. Ms. Hara is rated as an Elite expert by MediFind in the treatment of Milroy Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Lymphedema, Milroy Disease, Lymphangiectasis, Hysterectomy, and Lymphadenectomy.

What are the latest Milroy Disease Clinical Trials?
A National Prospective Cohort for Pregnancies in Patients With Rare Vascular Anomalies: COGRare5 Study

Summary: There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome or related, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby. The purpose of this Nationa...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?

Summary: Lymphedema is a debilitating disorder that severely impairs the quality of life of the patients and requires life-long attention. Treatment for lymphatic dysfunction remains largely symptomatic, without real cure. According to the International Society of Lymphology, lymphedema has to be treated with Decongestive Lymphatic Therapy. Research in the lab of Angiogenesis and Vascular Metabolism (PCA l...

Who are the sources who wrote this article ?

Published Date: April 01, 2013
Published By: National Institutes of Health